MCID: CYS018
MIFTS: 59

Cystitis

Categories: Nephrological diseases

Aliases & Classifications for Cystitis

MalaCards integrated aliases for Cystitis:

Name: Cystitis 12 54 43 15 62 17 71 32
Infective Cystitis 71

Classifications:



External Ids:

Disease Ontology 12 DOID:1679
ICD9CM 34 595 595.9
MeSH 43 D003556
NCIt 49 C26738
SNOMED-CT 67 38822007
ICD10 32 N30 N30.9
UMLS 71 C0010692 C0600041

Summaries for Cystitis

PubMed Health : 62 About cystitis: Many women know the symptoms of cystitis (a urinary tract infection, or UTI) only too well: frequent trips to the bathroom and a stinging and burning sensation when passing urine. Although these symptoms are often very unpleasant, there are effective treatments. Uncomplicated cystitis usually clears up without any problems. Unfortunately, there is no sure-fire way to reliably prevent cystitis. And a lot of the common strategies women may use in day-to-day life have not yet been scientifically tested. This article is about acute cystitis – a bladder infection often also referred to as a urinary tract infection (UTI). It is not about chronic bladder problems such as interstitial cystitis. It also doesn't include information about treating cystitis in pregnant women.

MalaCards based summary : Cystitis, also known as infective cystitis, is related to chronic cystitis and acute cystitis. An important gene associated with Cystitis is UMOD (Uromodulin), and among its related pathways/superpathways are ERK Signaling and TGF-Beta Pathway. The drugs Piroxicam and Lornoxicam have been mentioned in the context of this disorder. Affiliated tissues include prostate, bone and bone marrow, and related phenotypes are behavior/neurological and cardiovascular system

Disease Ontology : 12 A bladder disease that is characterized by inflammation of the bladder.

Wikipedia : 74 A urinary tract infection (UTI) is an infection that affects part of the urinary tract. When it affects... more...

Related Diseases for Cystitis

Diseases in the Cystitis family:

Acute Cystitis Chronic Cystitis

Diseases related to Cystitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 911)
# Related Disease Score Top Affiliating Genes
1 chronic cystitis 34.4 UPK3A UPK1A TRPV1 TAC1 P2RX3 NGF
2 acute cystitis 34.4 VIM UPK3A UPK1A UMOD TNF TLR4
3 interstitial cystitis 34.2 UPK3A UPK1A UMOD TRPV1 TACR1 TAC1
4 urethral syndrome 33.4 TAC1 P2RX3 NGF IL6 CXCL8
5 pyuria 31.9 IL6 CXCL8 CRP
6 pyelonephritis 31.9 UMOD TNF TLR4 IL6 CXCL8 CRP
7 bacteriuria 31.9 UMOD TLR4 IL6 CXCL8 CRP
8 graft-versus-host disease 31.8 TNF IL6 IL2
9 hydronephrosis 31.7 UPK3A IL6 EGF CXCL8 CRP
10 acute graft versus host disease 31.7 TNF IL4 IL2
11 prostatitis 31.7 TP53 TNF IL6 IL4 IL2 CXCL8
12 acute pyelonephritis 31.5 IL6 CXCL8 CRP
13 urinary tract obstruction 31.5 UPK3A UMOD HBEGF EGF CRP
14 fibromyalgia 31.5 TNF TACR1 NGF IL6 IL2 CXCL8
15 urethritis 31.5 TNF TLR4 IL6 CXCL8 CRP
16 bladder cancer 31.5 UPK3A UPK1A TP53 TNF IL2 HBEGF
17 vesicoureteral reflux 1 31.4 UPK3A UPK1A UMOD CXCL8 CRP
18 bacterial infectious disease 31.4 TNF TLR4 IL6 CXCL8 CRP
19 neurogenic bladder 31.4 UPK3A TRPV1 TACR1 TAC1 P2RX3 NGF
20 autoimmune disease 31.3 TNF IL6 IL4 IL2 CXCL8 CRP
21 irritable bowel syndrome 31.3 TRPV1 TNF TLR4 TACR1 TAC1 NGF
22 vaginal discharge 31.3 IL6 CXCL8 CRP
23 vaginitis 31.3 TNF TLR4 IL6 CXCL8
24 acute kidney failure 31.3 UMOD KNG1 EGF
25 chronic fatigue syndrome 31.2 TNF TLR4 IL6 IL4 IL2 CXCL8
26 peritonitis 31.2 TNF TLR4 IL6 IL4 CXCL8 CRP
27 ileus 31.1 TNF IL6 CRP
28 allergic hypersensitivity disease 31.1 TNF TLR4 KNG1 IL4 IL2 CXCL8
29 cholecystitis 31.1 TP53 TLR4 EGF
30 diarrhea 31.1 TNF TLR4 TAC1 IL6 IL2 CXCL8
31 pyelitis 31.1 UPK3A UPK1A UMOD TNF TLR4 IL6
32 chlamydia 31.0 TNF TLR4 IL6 IL4 CXCL8 CRP
33 paine syndrome 31.0 TRPV1 TACR1 TAC1 P2RX3 NGF KNG1
34 cytomegalovirus infection 31.0 TNF IL6 CXCL8
35 aplastic anemia 31.0 TP53 TNF IL6 IL4 IL2 CXCL8
36 endocarditis 30.9 TNF IL6 CXCL8 CRP
37 exanthem 30.9 TNF IL6 IL2 CXCL8 CRP
38 conjunctivitis 30.9 TNF IL6 IL4 IL2 CXCL8
39 purpura 30.9 TNF IL6 IL4 CRP
40 spinal cord injury 30.9 TNF IL6 CXCL8
41 gastroenteritis 30.9 TNF IL6 IL4 CXCL8 CRP
42 allergic rhinitis 30.9 NGF KNG1 IL4 CXCL8
43 toxic shock syndrome 30.9 TNF TLR4 IL6 IL4 IL2 CXCL8
44 schistosomiasis 30.9 TP53 TNF IL4 IL2
45 rhinitis 30.9 TNF NGF KNG1 IL6 IL4 CXCL8
46 typhoid fever 30.9 TNF TLR4 IL6 CRP
47 pancreatitis 30.9 TP53 TNF IL6 CRP
48 trichomoniasis 30.9 TNF IL6 IL2 CXCL8
49 colitis 30.9 TNF TLR4 IL6 IL4 IL2 CXCL8
50 anxiety 30.9 TNF TAC1 NGF IL6 CRP

Comorbidity relations with Cystitis via Phenotypic Disease Network (PDN): (show all 29)


Active Peptic Ulcer Disease Acute Cystitis
Acute Kidney Failure Alzheimer Disease
Bladder Cancer Bladder Neck Obstruction
Bronchitis Decubitus Ulcer
Deficiency Anemia Esophagitis
Familial Atrial Fibrillation Generalized Atherosclerosis
Heart Disease Hydronephrosis
Hypertension, Essential Hypothyroidism
Iron Deficiency Anemia Neurogenic Bladder
Osteoporosis Paralytic Ileus
Parkinson Disease, Late-Onset Prostatic Hypertrophy
Protein-Energy Malnutrition Pyelonephritis
Radiation Cystitis Schizophreniform Disorder
Transient Cerebral Ischemia Urethral Stricture
Urethritis

Graphical network of the top 20 diseases related to Cystitis:



Diseases related to Cystitis

Symptoms & Phenotypes for Cystitis

MGI Mouse Phenotypes related to Cystitis:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.28 HBEGF IL2 IL6 KNG1 NGF P2RX3
2 cardiovascular system MP:0005385 10.25 CRP HBEGF IL2 IL6 NGF P2RX3
3 homeostasis/metabolism MP:0005376 10.24 CRP HBEGF IL2 IL4 IL6 NGF
4 immune system MP:0005387 10.13 CRP EGF IL2 IL4 IL6 P2RX3
5 integument MP:0010771 10.03 EGF HBEGF IL4 IL6 NGF P2RX3
6 renal/urinary system MP:0005367 9.76 IL4 IL6 TAC1 TLR4 TP53 TRPV1
7 respiratory system MP:0005388 9.65 HBEGF IL2 IL4 IL6 P2RX3 TACR1
8 vision/eye MP:0005391 9.28 EGF IL2 IL4 IL6 NGF TLR4

Drugs & Therapeutics for Cystitis

PubMed Health treatment related to Cystitis: 62

For many women, cystitis is a one-time unpleasant problem. In others, it may keep coming back. Antibiotics have been proven to effectively relieve acute cystitis , and they usually work quickly. There are also some home remedies that may help, like drinking plenty of fluids or applying heat. Herbal products are available too.

Drugs for Cystitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 308)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Piroxicam Approved, Investigational Phase 4 36322-90-4 5280452 54676228
2
Lornoxicam Approved, Investigational Phase 4 70374-39-9 5282204
3
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
4
Oxybutynin Approved, Investigational Phase 4 5633-20-5 4634
5
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 68602 5311068
6
Ibuprofen Approved Phase 4 15687-27-1 3672
7
Morphine Approved, Investigational Phase 4 57-27-2 5288826
8
Oxytocin Approved, Vet_approved Phase 4 50-56-6 439302 53477758
9
Acetaminophen Approved Phase 4 103-90-2 1983
10
Cycloserine Approved Phase 4 68-41-7 401 6234
11
Azithromycin Approved Phase 4 83905-01-5 55185 447043
12
Cephalexin Approved, Investigational, Vet_approved Phase 4 15686-71-2 27447
13
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
14
Belladonna Approved, Experimental Phase 4
15
Methylene blue Approved, Investigational Phase 4 61-73-4
16
Metoprolol Approved, Investigational Phase 4 51384-51-1, 37350-58-6 4171
17
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741
18
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
19
Methenamine Approved, Vet_approved Phase 4 100-97-0 4101
20
Norfloxacin Approved Phase 4 70458-96-7 4539
21
Sodium citrate Approved, Investigational Phase 4 68-04-2
22
Fosfomycin Approved Phase 4 23155-02-4 446987
23
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
24
Cefotaxime Approved Phase 4 63527-52-6 456256 5742673
25
Imipenem Approved Phase 4 64221-86-9, 74431-23-5 104838
26
Cefoxitin Approved Phase 4 35607-66-0 441199
27
Cilastatin Approved, Investigational Phase 4 82009-34-5 5280454 6435415
28
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
29
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
30
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
31
BCG vaccine Investigational Phase 4
32 Pharmaceutical Solutions Phase 4
33 Gentamicins Phase 4
34 Solifenacin succinate Phase 4 242478-38-2
35 Ketorolac Tromethamine Phase 4
36 Mandelic Acids Phase 4
37 Muscarinic Antagonists Phase 4
38 Parasympatholytics Phase 4
39 Narcotics Phase 4
40 Analgesics, Opioid Phase 4
41 Adrenergic alpha-2 Receptor Agonists Phase 4
42 Amdinocillin Pivoxil Phase 4
43 Opiate Alkaloids Phase 4
44 Oxytocics Phase 4
45 Adrenergic Agents Phase 4
46 Anti-Infective Agents, Local Phase 4
47 Acriflavine Phase 4
48 Contraceptives, Oral Phase 4
49 Contraceptive Agents Phase 4
50 Contraceptives, Oral, Combined Phase 4

Interventional clinical trials:

(show top 50) (show all 339)
# Name Status NCT ID Phase Drugs
1 Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder Syndrome Unknown status NCT01312259 Phase 4
2 Solifenacin vs Levofloxacin vs Lornoxicam for Management of Intravesical Instillation of Bacillus Calmette-Guerin (BCG) Side Effects A Single Blinded Randomised Controlled Study Unknown status NCT03038321 Phase 4 sofenacin;Tavanic;Xefo
3 Botox on Vulvar Vestibulitis Unknown status NCT00119886 Phase 4 Botulinum toxin
4 Randomised Clinical Trial Comparing Fosfomycin vs. Nitrofurantoin for Treatment of Uncomplicated Lower Urinary Tract Infection in Female Adults at Increased Risk of Antibiotic-resistant Bacterial Infection Unknown status NCT01966653 Phase 4 nitrofurantoin;fosfomycin
5 Randomized Placebo-Controlled Trial of Gentamicin Bladder Instillation for the Prevention of Urinary Tract Infection in Adults at High Risk for Cystitis Due to Intermittent Catheterization Unknown status NCT01884467 Phase 4 Gentamicin;Placebo
6 Botulinum A Toxin Intravesical Injections Versus Bladder Overdistension in the Treatment of Patients With Painful Bladder Syndrome: A Prospective Randomized Study Unknown status NCT01157507 Phase 4 Intravesical injection of Botulinum A Toxin;Placebo
7 To Evaluate the Efficacy, Tolerability, and Safety of Intranasal Ketorolac Tromethamine (Sprix) as an Option for Acute (up to 5 Days) Pain Management Adult Interstitial Cystitis Patients Experiencing a Flare of Pain Completed NCT02000401 Phase 4 Ketorolac Tromethamine
8 Efficacy of Combined Intravesical Therapy With Hyaluronic Acid and Chondroitin Sulphate in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract: a Multicenter, Prospective Study Completed NCT02366676 Phase 4 hyaluronic acid and chondroitin sulphate
9 A Pilot Comparison of Short-course Nitrofurantoin in Females With Uncomplicated Bacterial Cystitis in the Emergency Department Completed NCT01749605 Phase 4 Nitrofurantoin monohydrate/macrocrystals 100 mg BID x 3 days;ciprofloxacin 250 mg BID x 3 days
10 Efficacy of Oxybutynin in Paediatric Cystitis Completed NCT03877289 Phase 4 Oxybutynin
11 The Impact of Injection Location on the Efficacy of Intravesicular Onabotulinumtoxin A in Interstitial Cystitis--Phase 4 Completed NCT02297100 Phase 4 Onabotulinumtoxin A
12 Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis Completed NCT01195116 Phase 4 Dexmedetomidine;Normal Saline
13 Ibuprofen Versus Mecillinam for Uncomplicated Cystitis in Adult, Non-pregnant Women Completed NCT01849926 Phase 4 Ibuprofen;Mecillinam
14 Use of Standardized Delegation Form in Diagnosing and Treating Acute Cystitis in Primary Care Facilities. Completed NCT01132131 Phase 4
15 Reduction of Bladder Injection Pain With Belladonna Opiate Suppository: A Randomized, Double-Blind, Placebo-Controlled Trial (ROBIN Trial) Completed NCT02600715 Phase 4 Onabotulinumtoxin A (BoNT);belladonna;Morphine;Placebo;Active B&O suppository of belladonna
16 Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis Completed NCT00919802 Phase 4 Oxytocin
17 Botox (Botulinum Toxin A) as a Treatment for Interstitial Cystitis in Women: A Randomized Placebo Controlled Trial Completed NCT00194610 Phase 4 Botox
18 Brain Imaging-based Strategies for Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain Completed NCT02385266 Phase 4 D-Cycloserine;Placebo (for D-cycloserine)
19 Ciprofloxacin for Prevention of BK Infection in Renal Transplant Recipients Completed NCT01789203 Phase 4 Ciprofloxacin;placebo
20 Detection and Treatment Benefit of Microorganism (Chlamydia Trachomatis, Mycoplasma Hominis, Ureaplasma Urealyticum) in Overactive Bladder Patients Completed NCT00883818 Phase 4 azithromycin, doxycycline
21 Management of Sub-Clinical Bacteriuria in Pregnancy: A Feasibility Trial Recruiting NCT03275623 Phase 4 Antibiotic
22 Clinical Assessment of Urinary Antiseptics Methenamine and Methylthioninium in Recurrent Cystitis Recruiting NCT03379389 Phase 4 Methenamine + Methylthioninium;Methenamine + Methylthioninium + Acriflavine + Atropa belladona;Antibiotics
23 Deciphering the Hormonal and Nociceptive Mechanisms Underlying Bladder Pain Recruiting NCT02214550 Phase 4 microgestin 1/20
24 Interstitial Cystitis: Examination of the Central Autonomic Network Recruiting NCT03008382 Phase 4 Metoprolol Tartrate Oral Tablet;Placebo Oral Tablet
25 Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen Recruiting NCT02431897 Phase 4 Conjugated Estrogens Cream;Placebo Cream
26 A Prospective Cohort Trial of Pelvic Floor Chemodenervation in Patients Undergoing Physical Therapy for High Tone Pelvic Floor Dysfunction Active, not recruiting NCT03199534 Phase 4 Botulinum toxin A 50u;Botulinum toxin A 100u;Botulinum toxin A 150u
27 Non-antimicrobial Alternative in Prophylaxis of Recurrent Urinary Tract Infections: a Prospective, Randomised-controlled, Double-blinded, Multicentre Study Not yet recruiting NCT04095572 Phase 4
28 Noroxin Efficacy and Safety Trial Not yet recruiting NCT03506256 Phase 4 Norfloxacin 400 MG
29 The Effects of Sequential Mitomycin and Bacillus Calmette-Guérin Treatment Versus Bacillus Calmette-Guérin Monotherapy in Patients With High Risk Non-Muscle Invasive Bladder Cancer Not yet recruiting NCT03790384 Phase 4 Mitomycin
30 Examining the Effects of Ketamine Treatment on Synaptic Plasticity in Depression Using PET Imaging Not yet recruiting NCT04091971 Phase 4 Ketamine
31 The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing Due to New Episodes of Urinary Tract Infections (UTI) in Elderly Women With Recurrent UTI - a Triple- Blinded, Randomized Placebo-controlled Phase IV Study Not yet recruiting NCT04077580 Phase 4 Methenamine Hippurate 1000 MG
32 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Evaluation of the Efficacy and Tolerability of Two Different Doses of ELMIRON for the Treatment of Interstitial Cystitis Terminated NCT00086684 Phase 4 Pentosan polysulfate sodium 100 mg;Placebo;Pentosan polysulfate sodium 100 mg
33 Efficacy of Gralise® for Chronic Pelvic Pain Terminated NCT01678911 Phase 4 Gralise
34 Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli Terminated NCT02474706 Phase 4 Cefoxitin;imipenem
35 Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective, Randomised,Placebo-controlled, Double-blind Study Terminated NCT01879930 Phase 4 doxycycline;placebo
36 The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study Terminated NCT00164099 Phase 4 Synbiotic 2000
37 Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type III Terminated NCT00194597 Phase 4 Viagra (sildenafil citrate)
38 Symptomatic Therapy of Uncomplicated Lower Urinary Tract Infections in the Ambulatory Setting. A Randomized, Double Blind Trial Terminated NCT01039545 Phase 4 Diclofenac;Norfloxacin
39 Nitrofurantoin Macrocrystals 3 Days Vs. 7 Days in the Treatment of Women With Uncomplicated Cystitis Withdrawn NCT00361998 Phase 4 NITROFURANTOIN MACROCRYSTALS
40 Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL) Producing and AmpC Hyperproducing Enterobacteriaceae in United Kingdom Withdrawn NCT01543347 Phase 4 Temocillin
41 A Double-Blind, Randomized Study of Puncturing Versus Non-Puncturing Acupuncture for the Treatment of Interstitial Cystitis Symptoms Unknown status NCT00094874 Phase 3
42 Phase III Randomized Trial of Comparing CCRT vs. RT Alone for Cervical Cancer Patients Primarily Treated by Radiotherapy and With Clinically Defined Good-prognosis Unknown status NCT00846508 Phase 3 Cisplatin
43 Randomized Comparison of Cyclophosphamide Versus Fludarabine in Addition to Anti-thymocyte Globulin for the Conditioning Therapy in Allogeneic Hematopoietic Cell Transplantation for Adult Acquired Aplastic Anemia Unknown status NCT01145976 Phase 3 Cy-ATG;Flu-ATG
44 An Investigator Initiated, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of Humira® (Adalimumab) For The Treatment of Interstitial Cystitis(IC) Completed NCT01295814 Phase 3 Adalimumab
45 Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis Completed NCT02497976 Phase 3 Placebo
46 Explorative Study on the Use of Omalizumab in Patients Suffering From Interstitial Cystitis/Painful Bladder Syndrome Completed NCT01294878 Phase 3 omalizumab
47 Multicentre, Prospective, Comparative, Randomized, Double-blind, Double-dummy Study to Assess the Efficacy and Safety of Cefditoren Pivoxil vs. Ciprofloxacin in Uncomplicated Acute Cystitis Completed NCT00598403 Phase 3 cefditoren pivoxil;Ciprofloxacin
48 A Randomized Multicenter Clinical Trial to Evaluate the Efficacy of Amitriptyline for the Treatment of Painful Bladder Syndrome (PBS) in Newly Diagnosed Patients Completed NCT00124306 Phase 3 Amitriptyline
49 URACYST® For the Treatment of GAG Deficient Interstitial Cystitis Completed NCT00150488 Phase 2, Phase 3
50 Radiation Induced Cystitis Treated With Hyperbaric Oxygen - A Randomized Controlled Trial Completed NCT01659723 Phase 2, Phase 3 Hyperbaric Oxygen

Search NIH Clinical Center for Cystitis

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Carboprost
Ciprofloxacin
Mesna
Methenamine
methenamine hippurate
methenamine mandelate
METHENAMINE SULFOSALICYLATE

Cochrane evidence based reviews: cystitis

Genetic Tests for Cystitis

Anatomical Context for Cystitis

MalaCards organs/tissues related to Cystitis:

40
Prostate, Bone, Bone Marrow, Kidney, Testes, T Cells, Spinal Cord

Publications for Cystitis

Articles related to Cystitis:

(showing 10976, show less)
# Title Authors PMID Year
1
Endogenous nerve growth factor regulates collagen expression and bladder hypertrophy through Akt and MAPK pathways during cystitis. 54 61
19996110 2010
2
Convergence of sensory pathways in the development of somatic and visceral hypersensitivity. 54 61
16500917 2006
3
GAP-43 immunoreactivity of subepithelial and detrusor muscle nerve fibres in patients with refractory idiopathic detrusor overactivity. 54 61
15924356 2005
4
Potential therapeutic targets for neurokinin-1 receptor antagonists. 54 61
15155133 2004
5
Neurokinin-1 (NK-1) receptor is required in antigen-induced cystitis. 54 61
10702392 2000
6
Increased expression of growth-associated protein (GAP-43) in lower urinary tract pathways following cyclophosphamide (CYP)-induced cystitis. 54 61
10536274 1999
7
[Evaluation of N-acetyl-beta glucosaminidase in upper and lower urinary tract infections in childhood. Clinical study of 168 children]. 54 61
9064498 1996
8
Tamm-Horsfall protein in bladder tissue. Morphologic spectrum and clinical significance. 54 61
8179076 1994
9
Urinary N-acetyl-beta-glucosaminidase and the selection of children for radiologic evaluation after urinary tract infection. 54 61
2371096 1990
10
The effect of Seidlitzia rosmarinus (eshnan) on the prevention of recurrent cystitis in women of reproductive age: A randomized, controlled, clinical trial. 61
31680378 2020
11
Cyclophosphamide-induced cystitis results in NLRP3-mediated inflammation in the hippocampus and symptoms of depression in rats. 61
31869244 2020
12
Current and Future Directions of Stem Cell Therapy for Bladder Dysfunction. 61
31758372 2020
13
Combination drug therapy against OAB normalizes micturition parameters and increases the release of nitric oxide during chemically induced cystitis. 61
32030913 2020
14
Effect of Vaginal Lactobacillus Species on Escherichia coli Growth. 61
31990804 2020
15
Translational aspects of Nuclear Factor - kappa B and its modulation by thalidomide on early and late radiation sequelae in urinary bladder dysfunction. 61
32035188 2020
16
Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients-Results of a Spanish multicenter cohort. 61
31550408 2020
17
Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats. 61
31522241 2020
18
Engineering Yarrowia lipolytica for Enhanced Production of Arbutin. 61
31903751 2020
19
Does clinical validation and the implementation of new models of outpatient service delivery have the potential to reduce waiting lists? A pilot study in Letterkenny University Hospital. 61
32030622 2020
20
MRI- and PET-Guided Interstitial Brachytherapy for Postsurgical Vaginal Recurrences of Cervical Cancer: Results of Phase II Study. 61
31682968 2020
21
Impact of extended infusional mesna prophylaxis on the incidence of BK viruria and hemorrhagic cystitis following post-transplantation cyclophosphamide and CTLA4Ig-based haploidentical transplantation. 61
32025839 2020
22
A study protocol of vaginal laser therapy in gynecological cancer survivors. 61
31474161 2020
23
Histamine induces peripheral and central hypersensitivity to bladder distension via the histamine H1 receptor and TRPV1. 61
31790304 2020
24
Urinary fungi associated with urinary symptom severity among women with interstitial cystitis/bladder pain syndrome (IC/BPS). 61
31028455 2020
25
Long noncoding RNA (MEG3) in urinal exosomes functions as a biomarker for the diagnosis of Hunner-type interstitial cystitis (HIC). 61
31595563 2020
26
Re: A Culture-Independent Analysis of the Microbiota of Female Interstitial Cystitis/Bladder Pain Syndrome Participants in the MAPP Research Network. 61
31721675 2020
27
The devil is in the details: observational study finds better outcomes for uncomplicated cystitis treated with fluoroquinolones. 61
31968271 2020
28
Antibiotic Prescribing in New York State Medicare Part B Beneficiaries Diagnosed With Cystitis Between 2016 and 2017. 61
31988975 2020
29
Two Case Reports of Integrated Management of Antibiotic-Resistant Urinary Tract Infection. 61
31958866 2020
30
Evaluation of the draft guidelines proposed by EMA and FDA for the clinical diagnosis of acute uncomplicated cystitis in women. 61
31004204 2020
31
[Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection]. 61
32003165 2020
32
Urinary microbiome in uncomplicated and interstitial cystitis: is there any similarity? 61
32006175 2020
33
Individualized Homeopathic Treatment in Women with Recurrent Cystitis: A Retrospective Case Series. 61
31945769 2020
34
Glandular-type inverted papilloma of urinary bladder - Report of a unique case with immunohistochemistry. 61
32031131 2020
35
Novel 3D organotypic urothelial cell culture model for identification of new therapeutic approaches in urological infections. 61
31986366 2020
36
Prevalence and risk factors of feline lower urinary tract disease in Chiang Mai, Thailand. 61
31932653 2020
37
Postmortem urinary tract changes in cats with urethral obstruction. 61
31989774 2020
38
ErbB2 Copy Number Aberration in Canine Urothelial Carcinoma Detected by a Digital Polymerase Chain Reaction Assay. 61
31640537 2020
39
[Focused Abdominal Ultrasound in Emergency, Perioperative and Intensive Care Medicine]. 61
31958858 2020
40
Opioid prescription use in patients with interstitial cystitis. 61
31980841 2020
41
Bioinformatics analysis of the Hub genes and key pathways of interstitial cystitis pathogenesis. 61
31663162 2020
42
Dramatically deteriorated quality of life in men with prostatitis-like symptoms. 61
31090261 2020
43
BK virus nephropathy without haemorrhagic cystitis following bone marrow transplantation. 61
31621066 2020
44
Cannabinoid receptor 2 activation decreases severity of cyclophosphamide-induced cystitis via regulating autophagy. 61
31729056 2020
45
High-definition ultrasound characterization of acute cyclophosphamide-induced cystitis in the mouse. 61
31942466 2020
46
Practitioner Education and Feedback to Decrease Ciprofloxacin Prescriptions in Patients with Acute Uncomplicated Cystitis. 61
31905331 2020
47
Concurrent urinary and bowel diversion: Surgical modification with sigmoid colon that avoids a bowel anastomosis. 61
31851467 2020
48
Low incidence of hemorrhagic cystitis following ex vivo T-cell depleted haploidentical hematopoietic cell transplantation in children. 61
31527820 2020
49
Effects and long-term follow-up of using umbilical cord blood-derived mesenchymal stromal cells in pediatric patients with severe BK virus-associated late-onset hemorrhagic cystitis after unrelated cord blood transplantation. 61
31944495 2020
50
Desmoplastic Small Round Cell Tumor: Long-Term Complications After Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. 61
30963398 2020
51
Infections after allogenic transplant with post-transplant cyclophosphamide: impact of donor HLA-matching. 61
32004700 2020
52
Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications. 61
31930750 2020
53
Voluntary exercise improves voiding function and bladder hyperalgesia in an animal model of stress-induced visceral hypersensitivity: A multidisciplinary approach to the study of urologic chronic pelvic pain syndrome research network study. 61
31944369 2020
54
Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent. 61
31970713 2020
55
Potential Probiotics Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 Co-Aggregate with Clinical Isolates of Proteus mirabilis and Prevent Biofilm Formation. 61
31989448 2020
56
Comparison of urodynamic results and quality of life between women with interstitial cystitis and overactive bladder. 61
32039798 2020
57
Association of Antibiotic Treatment Duration With Recurrence of Uncomplicated Urinary Tract Infection in Pediatric Patients. 61
31958969 2020
58
Symptom- and urinalysis-based approach to diagnosing urinary tract infections in children with neuropathic bladders. 61
31919595 2020
59
Condition-specific surveillance in health care-associated urinary tract infections as a strategy to improve empirical antibiotic treatment: an epidemiological modelling study. 61
31555835 2020
60
Evaluation of hematogenous spread and ascending infection in the pathogenesis of acute pyelonephritis due to group B streptococcus in mice. 61
31614193 2020
61
Cistus salviifolius Toxicity in Cattle. 61
31662123 2020
62
Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients: A Prospective Randomized Controlled Trial. 61
31959549 2020
63
Self-perception of symptoms, medical help seeking, and self-help strategies of women with interstitial cystitis/painful bladder syndrome. 61
31970901 2020
64
Painful interactions: Microbial compounds and visceral pain. 61
31634534 2020
65
BDNF promotes activation of astrocytes and microglia contributing to neuroinflammation and mechanical allodynia in cyclophosphamide-induced cystitis. 61
31931832 2020
66
Emphysematous cystitis leading to bladder necrosis and acute cystectomy - report of a rare case with fatal outcome. 61
31432726 2019
67
Evaluation of the trends and appropriateness of fluoroquinolone use in the outpatient treatment of acute uncomplicated cystitis at five family practice clinics. 61
31821580 2019
68
The efficacy of pentosan polysulfate monotherapy for preventing recurrent urinary tract infections in women: A multicenter open-label randomized controlled trial. 61
31813658 2019
69
First case of Serratia liquefaciens isolated from urinary tract infection in sows and associated clinicopathological and pathological findings. 61
31872893 2019
70
The Therapeutic Effect of Intravesical Instillation of Platelet Rich Plasma on Recurrent Bacterial Cystitis in Women: A Randomized Clinical Trial. 61
31535359 2019
71
Systemic complications of the bidirectional intraoperative chemotherapy with intravenous ifosfamide and hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin. 61
31799375 2019
72
[Current state of resistance of E. coli to trimethoprim in uncomplicated urinary tract infections in France]. 61
31757712 2019
73
Effect of a Herbal Therapy on Clinical Symptoms of Acute Lower Uncomplicated Urinary Tract Infections in Women: Secondary Analysis from a Randomized Controlled Trial. 61
31817885 2019
74
[Treatment of acute uncomplicated cystitis in women with antibiotic allergy or intolerance]. 61
31808635 2019
75
Impact of radiological diagnostics in the survivor of disseminated Fournier gangrene patient with septic pulmonary embolism. 61
31852690 2019
76
Long term follow-up of Behçet's syndrome patients treated with cyclophosphamide. 61
31840168 2019
77
A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results. 61
31419510 2019
78
The Occurrence of Multidrug Resistant Bacteria in the Urine of Healthy Dogs and Dogs with Cystitis. 61
31817523 2019
79
[Experience of using fosfomycin for the treatment of acute uncomplicated cystitis in women in postpartum period]. 61
31808628 2019
80
Radiation-induced cystitis and hyperbaric oxygen therapy. 61
31797786 2019
81
Evolution in technique of robotic intracorporeal continent catheterizable pouch after cystectomy. 61
31893282 2019
82
BK polyomavirus-pathogen, paradigm and puzzle. 61
31891401 2019
83
Current Management of Urinary Tract Infection and Vesicoureteral Reflux. 61
31828601 2019
84
Lupus cystitis: unusual cause of renal failure in systemic lupus erythematosus. 61
31862817 2019
85
[Toxicity of quinolone antibiotics - new untoward effects and reevaluation of known side effects]. 61
31791074 2019
86
Possibility of BK Virus-associated Nephropathy in Hospitalized Burn Patients. 61
31867602 2019
87
Prospective Analysis of Hemorrhagic Cystitis and BK Viremia in Allogeneic Hematopoietic Stem Cell Transplantation 61
31852035 2019
88
Intravesicular Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation. 61
31876431 2019
89
Differences between Community- and Hospital-acquired urinary tract infections in a tertiary care hospital. 61
31814033 2019
90
Neutropenia and renal dysfunction due to intravesical cidofovir for virus-associated hemorrhagic cystitis after kidney and allogenic hematopoietic stem cell transplantations. 61
31571390 2019
91
The natural history of BK polyomavirus and the host immune response after stem cell transplantation. 61
31851312 2019
92
Association of serum vitamin D levels and urinary tract infection in pregnant women: A case control study. 61
31671292 2019
93
Is Piperacillin-Tazobactam Effective for the Treatment of Pyelonephritis Caused by ESBL-producing Organisms? 61
31859352 2019
94
Antibiotic Resistance Among Uropathogenic Escherichia coli. 61
31880885 2019
95
Inhibition of urease activity in the urinary tract pathogens Staphylococcus saprophyticus and Proteus mirabilis by dimethylsulfoxide (DMSO). 61
31860153 2019
96
Utility of DNA Next-Generation Sequencing and Expanded Quantitative Urine Culture in Diagnosis and Management of Chronic or Persistent Lower Urinary Tract Symptoms. 61
31619534 2019
97
[Erratum to: Diagnosis and treatment of interstitial cystitis (IC/PBS). S2k guideline of the German Society of Urology]. 61
31776628 2019
98
Dysregulation of bladder corticotropin-releasing hormone receptor in the pathogenesis of human interstitial cystitis/bladder pain syndrome. 61
31844086 2019
99
Serum sphingosine-1-phosphate levels in bladder pain syndrome/interstitial cystitis patients: could it help in diagnosis? 61
31792578 2019
100
Synergistic Effects of N-Acetylcysteine and Mesenchymal Stem Cell in a Lipopolysaccharide-Induced Interstitial Cystitis Rat Model. 61
31905757 2019
101
Therapeutic Endoscopic Treatment Plus Maintenance Dimethyl Sulfoxide Therapy Prolongs Recurrence-Free Time in Patients With Hunner Type Interstitial Cystitis: A Pilot Study. 61
31905280 2019
102
Ba-Wei-Die-Huang-Wan (Hachimi-jio-gan) can ameliorate ketamine-induced cystitis by modulating neuroreceptors, inflammatory mediators, and fibrogenesis in a rat model. 61
31541501 2019
103
Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial. 61
31537473 2019
104
Urinary tract infection and subclinical bacteriuria in cats: A clinical update. 61
31601143 2019
105
A nationwide cohort study of hospital contacts after surgical treatment for urinary incontinence. 61
31782980 2019
106
Biomarkers Implicated in Lower Urinary Tract Symptoms: Systematic Review and Pathway Analyses. 61
30925127 2019
107
Follicular cystitis in urine cytology: A clinical and cytopathologic study. 61
31587518 2019
108
Network analysis, and human and animal studies disclose the anticystitis glandularis effects of vitamin C. 61
31469455 2019
109
Small fiber polyneuropathy as a potential therapeutic target in interstitial cystitis/bladder pain syndrome. 61
31240362 2019
110
A new look at the etiology of interstitial cystitis/bladder pain syndrome: extraordinary cultivations. 61
31363960 2019
111
Advanced Management of Patients With Ulcerative Interstitial Cystitis/Bladder Pain Syndrome. 61
31442473 2019
112
To reveal pharmacological targets and molecular mechanisms of curcumol against interstitial cystitis. 61
31193808 2019
113
Potassium sensitivity test predicts hydrodistention efficacy in patients with bladder pain syndrome/interstitial cystitis. 61
31747364 2019
114
Clinical and morphological effects of hyperbaric oxygen therapy in patients with interstitial cystitis associated with fibromyalgia. 61
31690286 2019
115
[Diagnosis and treatment of interstitial cystitis (IC/PBS) : S2k guideline of the German Society of Urology]. 61
31659368 2019
116
Defining a Molecular Signature for Uropathogenic versus Urocolonizing Escherichia coli: The Status of the Field and New Clinical Opportunities. 61
31794727 2019
117
Hyperbaric oxygen for radiation cystitis. 61
31537474 2019
118
Severe Infectious Complications of Intravesical Bacillus Calmette-Guérin: A Case Series of 10 Patients. 61
31705946 2019
119
Upregulation of neurotrophins and transforming growth factor-β expression in the bladder may lead to nerve hyperplasia and fibrosis in patients with severe ketamine-associated cystitis. 61
31433072 2019
120
Emphysematous cystitis as a rare form of urinary tract infection. 61
31697263 2019
121
Reduced-Toxicity (BuFlu) Conditioning Is Better Tolerated but Has a Higher Second Transplantation Rate Compared to Myeloablative Conditioning (BuCy) in Children with Inherited Metabolic Disorders. 61
31751770 2019
122
Successful Outcome in Patients with Fanconi Anemia Undergoing T Cell-Replete Mismatched Related Donor Hematopoietic Cell Transplantation Using Reduced-Dose Cyclophosphamide Post-Transplantation. 61
31306778 2019
123
Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort. 61
31694837 2019
124
Pentosan Polysulfate Sodium Exposure and Drug-Induced Maculopathy in Commercially Insured Patients in the United States. 61
31899034 2019
125
Bladder endometriosis complicated with cystitis glandularis mimicking recurrence of uterine cervical cancer: the unique value of transvaginal ultrasound. 61
31765462 2019
126
Canadian Urological Association Best Practice Report: Pediatric hemorrhagic cystitis. 61
31763977 2019
127
Uroprotective effect of pantoprazole against cyclophosphamide-induced cystitis in mice. 61
30874926 2019
128
Identification and characterization of OmpT-like proteases in uropathogenic Escherichia coli clinical isolates. 61
31496120 2019
129
Serotonin exerts a direct modulatory role on bladder afferent firing in mice. 61
31520534 2019
130
Effectiveness of extended- versus normal-release nitrofurantoin for cystitis: an instrumental variable analysis. 61
31504584 2019
131
Improving clinical outcomes with lower motor voltage (≤3 V) during stage 1 sacral neuromodulation for interstitial cystitis or bladder pain syndrome. 61
31512775 2019
132
Differential expression of histamine receptors in the bladder wall tissues of patients with bladder pain syndrome/interstitial cystitis - significance in the responsiveness to antihistamine treatment and disease symptoms. 61
31718622 2019
133
Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome. 61
31752328 2019
134
Variations in bladder pain syndrome/interstitial cystitis (IC) definitions, pathogenesis, diagnostics and treatment: a systematic review and evaluation of national and international guidelines. 61
31073635 2019
135
Histological evidence supports low anesthetic bladder capacity as a marker of a bladder-centric disease subtype in interstitial cystitis/bladder pain syndrome. 61
31254048 2019
136
Experimental Cannabinoid 2 Receptor Activation by Phyto-Derived and Synthetic Cannabinoid Ligands in LPS-Induced Interstitial Cystitis in Mice. 61
31766439 2019
137
Using Botulinum Toxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome-Possible Pathomechanisms and Practical Issues. 61
31689912 2019
138
Outcomes of intravesical chondroitin-sulfate and combined hyaluronic-acid/chondroitin-sulfate therapy on female sexual function in bladder pain syndrome. 61
31254047 2019
139
Improving the barrier function of damaged cultured urothelium using chondroitin sulfate. 61
31774209 2019
140
Efficacy of instillation treatment with hyaluronic acid in relieving symptoms in patients with BPS/IC and uncomplicated recurrent urinary tract infections - Long-term results of a multicenter study. 61
31499170 2019
141
The association of vulvar pain and urological urgency and frequency: findings from a community-based case-control study. 61
31375872 2019
142
Female lower urinary tract microbiota do not associate with IC/PBS symptoms: a case-controlled study. 61
30993388 2019
143
The use of intravesical cidofovir for the treatment of adenovirus-associated haemorrhagic cystitis in a kidney transplant recipient. 61
31583099 2019
144
Evaluation of selected protein biomarkers of renal function in rats with an experimental model of acute cyclophosphamide-induced cystitis treated with N-acetylcysteine. 61
32009631 2019
145
Intravesical application of platelet-rich plasma in patients with persistent haemorrhagic cystitis after hematopoietic stem cell transplantation: a single-centre preliminary experience. 61
31321678 2019
146
Fungal Bezoars Mimicking an Enterovesica Fistula: A Unique Case Report. 61
31768178 2019
147
[Antimicrobial susceptibility of Escherichia coli producers of community urinary tract infections in Galicia (Spain). Period: 2016-2017]. 61
31607403 2019
148
Pharmacokinetics of Ertapenem in Sheep (Ovis aries) with Experimentally Induced Urinary Tract Infection. 61
31581974 2019
149
Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. 61
31608743 2019
150
Comparison of antibiotic treatment guidelines for urinary tract infections in 15 European countries: Results of an online survey. 61
31229671 2019
151
Neoadjuvant volumetric modulated arc radiochemotherapy with a simultaneous integrated boost technique compared to standard chemoradiation for locally advanced rectal cancer 61
31651118 2019
152
Ketamine induces endoplasmic reticulum stress in rats and SV-HUC-1 human uroepithelial cells by activating NLRP3/TXNIP aix. 61
31652453 2019
153
Fosfomycin Trometamol versus Comparator Antibiotics for the Treatment of Acute Uncomplicated Urinary Tract Infections in Women: A Systematic Review and Meta-Analysis. 61
31651226 2019
154
Bladder teratoma in a maned wolf (Chrysocyon brachyurus). 61
31998620 2019
155
Urinary tract infections in Australian aged care homes: Antibiotic prescribing practices and concordance to national guidelines. 61
31677924 2019
156
Depression and helplessness impact interstitial cystitis/bladder pain syndrome pain over time. 61
31364973 2019
157
Monoacylglycerol lipase inhibition as potential treatment for interstitial cystitis. 61
31443753 2019
158
Factors associated with hematuric struvite crystalluria in cats. 61
30392432 2019
159
Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy: Systematic review of the recent literature. 61
31617263 2019
160
Haemorrhagic cystitis, preventive and treatment interventions in patients undergoing haematopoietic stem cell transplantation: A scoping review. 61
31446264 2019
161
Improvement in adherence to antibiotic duration of therapy recommendations for uncomplicated cystitis: a quasi-experimental study. 61
31671172 2019
162
Antimicrobial resistance patterns of Uropathogens isolated from adult women with acute uncomplicated cystitis. 61
31666014 2019
163
Re: The IOU Consensus Recommendations for Empirical Therapy of Cystitis in Nursing Home Residents. 61
31298984 2019
164
Genomic profile of urine has high diagnostic sensitivity compared to cytology in non-invasive urothelial bladder cancer. 61
31368627 2019
165
[Intussusception Due to Inflammatory Polyp in the Ileum after ESD for Rectal LST]. 61
31631157 2019
166
An unusual case of Kaposi sarcoma masquerading as cystitis in a kidney transplant recipient. 61
31220395 2019
167
Superselective vesical artery embolization in the management of intractable hematuria secondary to hemorrhagic cystitis. 61
30560299 2019
168
Severe hemorrhagic cystitis caused by the BK polyomavirus is associated with decreased survival post-allogeneic hematopoietic stem cell transplantation. 61
31054192 2019
169
Promise and the Pharmacological Mechanism of Botulinum Toxin A in Chronic Prostatitis Syndrome. 61
31614473 2019
170
[Clinical observation of 12 patients with refractory/relapsed acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation containing cladribine regimen]. 61
31775481 2019
171
Results of Allogenic Hematopoietic Stem Cell Transplantation in Fanconi Anemia Caused by Bone Marrow Failure: Single-Regimen, Single-Center Experience of 14 Years. 61
31199982 2019
172
Impairment of cholinergic bladder contractility in rat model of type I diabetes complicated by cystitis: Contribution of neurotransmitter-degrading ectoenzymes. 61
31299187 2019
173
[Clinical effect of double filtration plasmapheresis combined with glucocorticoid and immunosuppressant in treatment of children with severe Henoch-Schönlein purpura nephritis]. 61
31642426 2019
174
Therapy of the rat hemorrhagic cystitis induced by cyclophosphamide. Stable gastric pentadecapeptide BPC 157, L-arginine, L-NAME. 61
31401154 2019
175
Quantification of fecal adenovirus viral load and correlation with Vesikari score in children with acute gastroenteritis. 61
31621273 2019
176
Reactivation of BK virus after double umbilical cord blood transplantation in adults correlates with impaired reconstitution of CD4+ and CD8+ T effector memory cells and increase of T regulatory cells. 61
31255803 2019
177
Suspected anaphylactic shock associated with administration of tranexamic acid in a dog. 61
31406035 2019
178
Candida urinary tract infections in adults. 61
31654220 2019
179
Antibiotic prescribing for acute uncomplicated cystitis in Lebanese community pharmacies using a simulated patient. 61
31897255 2019
180
Long-standing nonulcerative bladder pain syndrome: Impact of Thiele massage on bladder and sexual domains. 61
31647172 2019
181
Effect of Water Avoidance Stress on serum and urinary NGF levels in rats: diagnostic and therapeutic implications for BPS/IC patients. 61
31575913 2019
182
Bladder Hydrodistention Does Not Result in a Significant Change in Bladder Capacity for Interstitial Cystitis/Bladder Pain Syndrome Patients. 61
31299328 2019
183
Temperature-responsive silk-elastinlike protein polymer enhancement of intravesical drug delivery of a therapeutic glycosaminoglycan for treatment of interstitial cystitis/painful bladder syndrome. 61
31276948 2019
184
Activation of NFKB-JMJD3 signaling promotes bladder fibrosis via boosting bladder smooth muscle cell proliferation and collagen accumulation. 61
31102789 2019
185
A prospective randomized study of efficacy of 2 treatment protocols in preventing recurrence of clinical signs in 51 male cats with obstructive idiopathic cystitis. 61
31400046 2019
186
The effect of a therapeutic urinary stress diet on the short-term recurrence of feline idiopathic cystitis. 61
31532910 2019
187
Epigenetic regulation of COX‑2 expression by DNA hypomethylation via NF‑κB activation in ketamine‑induced ulcerative cystitis. 61
31257475 2019
188
Additional assessment of Acute Cystitis Symptom Score questionnaire for patient-reported outcome measure in female patients with acute uncomplicated cystitis: part II. 61
31549179 2019
189
[Experience of using the antibacterial drug Fosfomycin Esparma for the treatment of acute uncomplicated cystitis in women]. 61
31535800 2019
190
Is trigonitis a neglected, imprecise, misunderstood, or forgotten diagnosis? 61
30989795 2019
191
Induction Chemotherapy Reduces Patient-reported Toxicities During Neoadjuvant Chemoradiation with Intensity Modulated Radiotherapy for Rectal Cancer. 61
31104990 2019
192
Detection of multidrug resistance and extended-spectrum/plasmid-mediated AmpC beta-lactamase genes in Enterobacteriaceae isolates from diseased cats in Italy. 61
31524037 2019
193
Malakoplakia of the Bladder in a 4-Month-Old Puppy. 61
31433228 2019
194
Changes in Endogenous and Exogenous Koala Retrovirus Subtype Expression over Time Reflect Koala Health Outcomes. 61
31243137 2019
195
Ultrasound characteristics of feline urinary bladder transitional cell carcinoma are similar to canine urinary bladder transitional cell carcinoma. 61
31144408 2019
196
Poly-L-lysine as an Effective and Safe Desquamation Inducer of Urinary Bladder Epithelium. 61
31527451 2019
197
Clustering of Patients with Interstitial Cystitis/Bladder Pain Syndrome and Chronic Prostatitis/Chronic Pelvic Pain Syndrome. 61
30916629 2019
198
Cystitis Cystica on Routine Cystoscopy at Time of Total Laparoscopic Hysterectomy. 61
30735732 2019
199
Eosinophilic cystitis caused by Candida glabrata: A case report. 61
31380221 2019
200
Risks of interstitial cystitis among patients with systemic lupus erythematosus: A population-based cohort study. 61
31311067 2019
201
Incidence and Morbidity of Radiation-Induced Hemorrhagic Cystitis in Prostate Cancer. 61
31201826 2019
202
Definitive BCG immunotherapy versus radical cystectomy in intermediate or high-risk nonmuscle invasive bladder cancer patients: A retrospective study. 61
31490371 2019
203
The misdiagnosis of interstitial cystitis/bladder pain syndrome in a VA population. 61
31302944 2019
204
Hybrid Laparoscopic and Robotic Hepatopancreaticoduodenectomy for Cholangiocarcinoma. 61
31197693 2019
205
Heptylmannose-functionalized cellulose for the binding and specific detection of pathogenic E. coli. 61
31389420 2019
206
BK Polyomavirus Virus Glomerular Tropism: Implications for Virus Reactivation from Latency and Amplification during Immunosuppression. 61
31533282 2019
207
Potential of hyperbaric oxygen in urological diseases. 61
31083787 2019
208
Glycine tomentella hayata extract and its ingredient daidzin ameliorate cyclophosphamide-induced hemorrhagic cystitis and oxidative stress through the action of antioxidation, anti-fibrosis, and anti-inflammation. 61
31670282 2019
209
Seizure frequency in more than 180,000 treatment sessions with hyperbaric oxygen therapy - a single centre 20-year analysis. 61
31523791 2019
210
Current usage of qualitative research in female pelvic pain: a systematic review. 61
31201537 2019
211
Treatment with low-energy shock wave alleviates pain in an animal model of uroplakin 3A-induced autoimmune interstitial cystitis/painful bladder syndrome. 61
31501798 2019
212
Long-term outcome and symptom improvement in patients with interstitial cystitis/bladder pain syndrome with or without regular follow-up and treatment. 61
31310370 2019
213
Analysis of key genes and micro-RNA-mRNA regulatory networks in women with ulcerative interstitial cystitis/pain bladder syndrome. 61
30456462 2019
214
Phenotypic Spectrum of Pentosan Polysulfate Sodium-Associated Maculopathy: A Multicenter Study. 61
31486843 2019
215
Molecular determinants of afferent sensitization in a rat model of cystitis with urothelial barrier dysfunction. 61
31314637 2019
216
IC/BPS-associated alterations of M2 and M3 muscarinic acetylcholine receptor trafficking in human detrusor. 61
31301091 2019
217
Direct conversion of fibroblasts into urothelial cells that may be recruited to regenerating mucosa of injured urinary bladder. 61
31554870 2019
218
Biological Characterization and Inhibition of Streptococcus pyogenes ZUH1 Causing Chronic Cystitis by Crocus sativus Methanol Extract, Bee Honey Alone or in Combination with Antibiotics: An In Vitro Study. 61
31405067 2019
219
Clinical implications of the anatomical position of the urethra meatus in women with recurrent post-coital cystitis: a case-control study. 61
29968091 2019
220
UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens. 61
31320216 2019
221
The use of nitrofurantoin for children with acute cystitis caused by extended-spectrum Β-lactamase-producing Escherichia coli. 61
31014984 2019
222
Is it possible to extrapolate the rates of resistance of Escherichia coli from asymptomatic bacteriuria in pregnant women to those of E. coli in uncomplicated community-acquired UTI? 61
31328907 2019
223
Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. 61
31042112 2019
224
The Point Prevalence Survey Research of Antibacterial Drugs' Prescription for Outpatient Treatment of Urinary System Infections. 61
31666863 2019
225
The Severity and Distribution of Nonurologic Pain and Urogenital Pain in Overactive Bladder are Intermediate Between Interstitial Cystitis and Controls. 61
31034917 2019
226
Molecular pathogenesis of interstitial cystitis/bladder pain syndrome based on gene expression. 61
30609029 2019
227
Is there an effective therapy of interstitial cystitis/bladder pain syndrome? 61
31070933 2019
228
Antibiotic-sparing agents for uncomplicated cystitis: uva-ursi and ibuprofen not ready for primetime. 61
31035018 2019
229
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Diagnostic Tool in the Assessment of Tumour Angiogenesis in Urinary Bladder Cancer. 61
30922786 2019
230
Targeting the SHIP1 Pathway Fails to Show Treatment Benefit in Interstitial Cystitis/Bladder Pain Syndrome: Lessons Learned from Evaluating Potentially Effective Therapies in This Enigmatic Syndrome. 61
31090511 2019
231
Anxiety severity does not influence treatment outcomes in patients with interstitial cystitis/bladder pain syndrome. 61
31059599 2019
232
Absolute lymphocyte count and human adenovirus-specific T-cell immune restoration of human adenovirus infection after kidney transplantation. 61
30905076 2019
233
Omadacycline: A Novel Tetracycline Derivative With Oral and Intravenous Formulations. 61
30893428 2019
234
Results of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction: Five-Year Experience of a Retrospective, Multicenter Study in China. 61
30609180 2019
235
Bottom-up and top-down profiling of pentosan polysulfate. 61
31287456 2019
236
Effect of distal esophageal irritation on the changes of cystometry parameters to esophagus and colon distentions in rats. 61
31013433 2019
237
Acyloxyacyl hydrolase modulates depressive-like behaviors through aryl hydrocarbon receptor. 61
31017816 2019
238
A closer look at the health of cats showing urinary house-soiling (periuria): a case-control study. 61
30261793 2019
239
Botulinum Neurotoxin A Intravesical Injections in Interstitial Cystitis/Bladder Painful Syndrome: A Systematic Review with Meta-Analysis. 61
31480323 2019
240
Molecular Taxonomy of Interstitial Cystitis/Bladder Pain Syndrome Based on Whole Transcriptome Profiling by Next-Generation RNA Sequencing of Bladder Mucosal Biopsies. 61
30865573 2019
241
Gangrenous cystitis: An extremely rare infectious condition managed by neobladder - A case report with review of literature. 61
31413514 2019
242
Recurrence rate and long-term course of cats with feline lower urinary tract disease. 61
31322040 2019
243
PACAP38-Mediated Bladder Afferent Nerve Activity Hyperexcitability and Ca2+ Activity in Urothelial Cells from Mice. 61
30022438 2019
244
von Hansemann Cells from Fresh Urine Sediment Samples in the Diagnosis of Malakoplakia. 61
31359917 2019
245
Development and implementation of a clinical decision support tool for treatment of uncomplicated urinary tract infections in a family medicine resident clinic. 61
31060794 2019
246
Management of BK-virus infection - Swedish recommendations. 61
31012777 2019
247
Re: Therapeutic Effects of Endoscopic Ablation in Patients with Hunner Type Interstitial Cystitis. 61
30958746 2019
248
Chronic scrotal pain: A variable symptom of interstitial cystitis/bladder pain syndrome. 61
31413503 2019
249
Lipoxygenase-5 Expression in Canine Urinary Bladder: Normal Urothelium, Cystitis and Transitional Cell Carcinoma. 61
31375151 2019
250
Encrusted cystitis detected by 18F-FDG PET/CT. 61
30638879 2019
251
Emphysematous cystitis: diagnosed only if suspected. 61
31320377 2019
252
The standardized herbal combination BNO 2103 contained in Canephron® N alleviates inflammatory pain in experimental cystitis and prostatitis. 61
31257118 2019
253
Tuberculosis epididymo-orchitis following intravesical bacillus Calmette-Guérin immunotherapy. 61
31360436 2019
254
Endovascular Management of Radiation-Induced Hemorrhagic Cystitis. 61
31413467 2019
255
Allogenic Hematopoietic Cell Transplantation in Thalassemia Major: A Single-center Retrospective Analysis From India. 61
30933028 2019
256
Equine Idiopathic Hemorrhagic Cystitis: Is It Idiopathic or More Likely to Be Exercise-Associated? 61
31203985 2019
257
Lack of uniformity among United States recommendations for diagnosis and management of acute, uncomplicated cystitis. 61
30099566 2019
258
Bacterial urinary tract infection among adult renal transplant recipients at St. Paul's hospital millennium medical college, Addis Ababa, Ethiopia. 61
31366333 2019
259
[Experience of application of hormonal and probiotic therapy in the complex treatment of women in peri- and postmenopausal with chronic recurrent bacterial cystitis in the background of vulvovaginal atrophy]. 61
31356015 2019
260
Intraepithelial neutrophils in mammary, urinary and gall bladder infections. 61
31324217 2019
261
Lupus intestinal pseudo-obstruction and hydronephrosis: Case report. 61
31305400 2019
262
PACAP/PAC1 Expression and Function in Micturition Pathways. 61
30259317 2019
263
Re: The Efficacy of Botulinum Toxin A and Sacral Neuromodulation in the Management of Interstitial Cystitis (IC)/Bladder Pain Syndrome (BPS), What do we Know? ICI-RS 2017 Think Tank, Bristol. 61
30958748 2019
264
Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency. 61
31258287 2019
265
Cystitis-induced bladder pain is Toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP Research Network animal study. 61
31091120 2019
266
Sacral neuromodulation treating chronic pelvic pain: a meta-analysis and systematic review of the literature. 61
30874835 2019
267
Functional effects of blocking VEGF/VEGFR2 signaling in the rat urinary bladder in acute and chronic CYP-induced cystitis. 61
30995112 2019
268
UCA1 promotes cell viability, proliferation and migration potential through UCA1/miR-204/CCND2 pathway in primary cystitis glandularis cells. 61
30999112 2019
269
Second nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by Japanese Surveillance Committee from 2015 to 2016: antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus. 61
30905628 2019
270
Emphysematous cystitis in an 87 year old man. 61
31216170 2019
271
Urinary Tract Infections in College and Non-College Women from Colombia. 61
31260553 2019
272
The Urinary Microbiome and Anticancer Immunotherapy: The Potentially Hidden Role of Unculturable Microbes. 61
31073691 2019
273
Qualitative Analysis of Primary Care Provider Prescribing Decisions for Urinary Tract Infections. 61
31248119 2019
274
The pharmacokinetics of nitrofurantoin in healthy female volunteers: a randomized crossover study. 61
30859184 2019
275
MRI Radiomic Analysis of IMRT-Induced Bladder Wall Changes in Prostate Cancer Patients: A Relationship with Radiation Dose and Toxicity. 61
31176433 2019
276
Recurrent episodes of feline lower urinary tract disease with different causes: possible clinical implications. 61
29943625 2019
277
Allyl-isothiocyanate ameliorates the pre-neoplastic changes induced by the fern Dryopteris nigropalaceae on experimental feeding in Guinea pigs. 61
30782570 2019
278
Enhanced uropathogenic Escherichia coli-induced infection in uroepithelial cells by sugar through TLR-4 and JAK/STAT1 signaling pathways. 61
31296484 2019
279
Intravesical tacrolimus in treatment of intractable interstitial cystitis/bladder pain syndrome - A pilot study. 61
31144739 2019
280
Hunner lesion versus non-Hunner lesion interstitial cystitis/bladder pain syndrome. 61
31144757 2019
281
Suplatast tosilate in patients with interstitial cystitis: Efficacy and treatment possibilities, with suggestions for future assessments. 61
31144762 2019
282
Interstitial cystitis, bladder pain syndrome, hypersensitive bladder, and interstitial cystitis/bladder pain syndrome - clarification of definitions and relationships. 61
31144731 2019
283
Editorial Comment from Jane Meijlink to Interstitial cystitis, bladder pain syndrome, hypersensitive bladder, and interstitial cystitis/bladder pain syndrome - clarification of definitions and relationship. 61
31144733 2019
284
Editorial Comment from Dr Hanno to Interstitial cystitis, bladder pain syndrome, hypersensitive bladder, and interstitial cystitis/bladder pain syndrome - clarification of definitions and relationships. 61
31144741 2019
285
Patterns and predictors of Hunner lesion recurrence in patients with interstitial cystitis. 61
30945347 2019
286
Editorial Comment from Jane Meijlink to Pathophysiology of interstitial cystitis. 61
31144747 2019
287
Editorial Comment to Phenotyping of interstitial cystitis/bladder pain syndrome. 61
31144749 2019
288
Editorial Comment from Dr Hanno to Pathophysiology of interstitial cystitis. 61
31144760 2019
289
Editorial Comment from Dr Yoshimura to Pathophysiology of interstitial cystitis. 61
31144754 2019
290
Phenotyping of interstitial cystitis/bladder pain syndrome. 61
31144756 2019
291
Urinary bladder mass with emphysematous cystitis: double whammy. 61
31171537 2019
292
Emphysematous cystitis associated with voiding dysfunction from herpes zoster. 61
31160498 2019
293
[Efficiency of immunomodulatotors for complex therapy of chronic recurrent cystitis in women]. 61
31162894 2019
294
Sex steroid hormone receptors in bladder cancer: Usefulness in differential diagnosis and implications in histogenesis of bladder cancer. 61
30737158 2019
295
A systematic review of preventive and therapeutic options for symptoms of cystitis in patients with bladder cancer receiving intravesical bacillus Calmette-Guérin immunotherapy. 61
30870228 2019
296
Antibiotic Prescribing Quality in Out-of-Hours Primary Care and Critical Appraisal of Disease-Specific Quality Indicators. 61
31212871 2019
297
IPSE, a parasite-derived host immunomodulatory protein, is a potential therapeutic for hemorrhagic cystitis. 61
30785353 2019
298
Killer-cell immunoglobulin-like receptor ligand mismatch cord blood transplantation in high-risk neuroblastoma. 61
30974480 2019
299
[Multivariate Analysis of Factors Influencing Recovery from Hemorrhagic Cystitis after Allo-HSCT]. 61
31204964 2019
300
Pathophysiology of interstitial cystitis. 61
31144735 2019
301
Sexual pain and IC/BPS in women. 61
31170952 2019
302
Adenovirus Infection as a Cause of Fever of Unknown Origin and Allograft Dysfunction in a Kidney Transplant Recipient. 61
29025381 2019
303
Cystitis and Pyelonephritis: Diagnosis, Treatment, and Prevention. 61
31030820 2019
304
Concurrent emphysematous pyelonephritis (EPN) and emphysematous cystitis (EC) presenting with septic shock. 61
31171535 2019
305
Host and Bacterial Markers that Differ in Children with Cystitis and Pyelonephritis. 61
30905425 2019
306
Antibiotic Treatment Versus No Treatment for Asymptomatic Bacteriuria in Kidney Transplant Recipients: A Multicenter Randomized Trial. 61
31214630 2019
307
Neuregulin-1-ErbB signaling promotes microglia activation contributing to mechanical allodynia of cyclophosphamide-induced cystitis. 61
30989724 2019
308
Editorial Comment to Interstitial cystitis/bladder pain syndrome/hypersensitive bladder: worldwide confusion! what has gone wrong and how can we put it right for the sake of the patients? 61
31144736 2019
309
Editorial Comment to Minimally invasive device for intravesical instillation by urological syringe adapter (MID-ii U.S.A.) for catheter-free instillation therapy of the bladder in interstitial cystitis/bladder pain syndrome. 61
31144752 2019
310
Inhibition of microRNA-132 attenuates inflammatory response and detrusor fibrosis in rats with interstitial cystitis via the JAK-STAT signaling pathway. 61
30582204 2019
311
Interstitial cystitis/bladder pain syndrome/hypersensitive bladder: Worldwide confusion! What has gone wrong and how can we put it right for the sake of the patients? 61
31144742 2019
312
Editorial Comment to Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome. 61
31144743 2019
313
Editorial Comment to Low bladder capacity is an important predictor for comorbidity of interstitial cystitis with hunner's lesion in patients with refractory chronic prostatitis/chronic pelvic pain syndrome. 61
31144748 2019
314
Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome. 61
31144750 2019
315
Minimally invasive device for intravesical instillation by urological syringe adapter (MID-ii U.S.A.) for catheter-free instillation therapy of the bladder in interstitial cystitis/bladder pain syndrome. 61
31144753 2019
316
Low bladder capacity is an important predictor for comorbidity of interstitial cystitis with Hunner's lesion in patients with refractory chronic prostatitis/chronic pelvic pain syndrome. 61
31144759 2019
317
Editorial Comment from Dr Homma to Hunner lesion versus non-hunner lesion interstitial cystitis/bladder pain syndrome. 61
31144758 2019
318
Editorial Comment from Dr Hanno to Intravesical tacrolimus in treatment of intractable bladder pain syndrome/interstitial cystitis-a pilot study. 61
31144763 2019
319
4th International Consultation on Interstitial Cystitis, Japan (ICICJ) and the Annual Meeting of the Society of Interstitial Cystitis of Japan (SICJ), 17-18 April 2018, Kyoto International Conference Center, Kyoto, Japan. 61
31144740 2019
320
Editorial Comment from Dr Homma to Intravesical tacrolimus in treatment of intractable bladder pain syndrome/interstitial cystitis-a pilot study. 61
31144738 2019
321
Editorial Comment from Dr Hanno to Hunner lesion versus non-hunner lesion interstitial cystitis/bladder pain syndrome. 61
31144751 2019
322
Antimicrobial resistance patterns in urinary E. coli isolates after a change in a single center's guidelines for uncomplicated cystitis in ambulatory settings. 61
30895921 2019
323
A survey for ketamine abuse and its relation to the lower urinary tract symptoms in Taiwan. 61
31076629 2019
324
National Patterns of Filled Prescriptions and Third-Line Treatment Utilization for Privately Insured Women With Overactive Bladder. 61
31157717 2019
325
Case report and video presentation: Trans-urethral resection of bladder endometriosis. 61
31211086 2019
326
Emphysematous cystitis: Retrospective evaluation of predisposing factors and ultrasound features in 36 dogs and 2 cats. 61
31080265 2019
327
Pre-test probability of urinary tract infection in dogs with clinical signs of lower urinary tract disease. 61
30971354 2019
328
Pharmacokinetics, Safety, and Clinical Outcomes of Omadacycline in Women with Cystitis: Results from a Phase 1b Study. 61
30858208 2019
329
Interstitial cystitis - intravesical treatment. 61
31066806 2019
330
High-dose intensity-modulated radiation therapy as primary treatment of prostate cancer: genitourinary/gastrointestinal toxicity and outcomes, a single-institution experience. 61
30607866 2019
331
Successful management of aberrant right hepatic duct during laparoscopic cholecystectomy: a rare case report. 61
31073708 2019
332
New perspectives for reassessing fosfomycin: applicability in current clinical practice. 61
31131586 2019
333
Assessment of HER2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder. 61
30612533 2019
334
Levofloxacin-associated Encephalopathy with Severe Hyperventilation. 61
30713304 2019
335
[Complications after intravesical BCG instillation]. 61
31120204 2019
336
MDCT Imaging of Acute Bladder Pathology. 61
31142434 2019
337
A Speech-Enabled Fixed-Phrase Translator for Emergency Settings: Crossover Study. 61
31066702 2019
338
Cystoscopic evaluation and clinical phenotyping in interstitial cystitis/bladder pain syndrome 61
30457110 2019
339
Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis. 61
31122535 2019
340
[Efficacy of electroacupuncture nerve stimulation therapy for interstitial cystitis/bladder pain syndrome]. 61
31099215 2019
341
A case of emphysematous cystitis and bladder rupture. 61
31211071 2019
342
Gas in the kidney in asymptomatic Escherichia coli urinary tract infections in a patient with severe vesicoureteral reflex. 61
31249237 2019
343
Recurrent Abdominal Pain in Systemic Lupus Erythematosus: Concurrent Lupus Enteritis and Lupus Cystitis. 61
30710539 2019
344
N-acetylcysteine prevents bladder tissue fibrosis in a lipopolysaccharide-induced cystitis rat model. 61
31148586 2019
345
Beyond an Obvious Cause of Cholestasis in a Toddler: Compound Heterozygosity for ABCB11 Mutations. 61
31015375 2019
346
Disseminated adenovirus infection in a patient with relapsed refractory multiple myeloma undergoing autologous stem cell transplantation and pomalidomide/dexamethasone as salvage regimens. 61
30642772 2019
347
Donor lymphocyte infusion for BK virus hemorrhagic cystitis and nephropathy: a case report. 61
30518978 2019
348
Uroprotective effect of ambroxol in cyclophosphamide-induced cystitis in mice. 61
30895504 2019
349
Single centre observational study on antibiotic prescribing adherence to clinical practice guidelines for treatment of uncomplicated urinary tract infection. 61
30598405 2019
350
Co-culture of Methanobrevibacter smithii with enterobacteria during urinary infection. 61
31072770 2019
351
International Society for Companion Animal Infectious Diseases (ISCAID) guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats. 61
30971357 2019
352
Bladder wall injection of mesenchymal stem cells ameliorates bladder inflammation, overactivity and nociception in a chemically induced interstitial cystitis-like rat model. 61
29600399 2019
353
[Medical prevention and treatment of radiation-induced urological and nephrological complications]. 61
30898418 2019
354
High Rates of Fosfomycin Resistance in Gram-Negative Urinary Isolates from Israel. 61
30724694 2019
355
Clinical description of Corynebacterium urealyticum urinary tract infections in 11 dogs and 10 cats. 61
30653665 2019
356
Machine Learning Approach to find the relation between Endometriosis, benign breast disease, cystitis and non-toxic goiter. 61
30932000 2019
357
Genome Sequence of a Facklamia hominis Isolate from a Patient with Urosepsis. 61
31023809 2019
358
Intravesical administration of blebbistatin prevents cyclophosphamide-induced toxicity of the urinary bladder in female Wistar rats. 61
30869827 2019
359
Urinary K+ promotes irritative voiding symptoms and pain in the face of urothelial barrier dysfunction. 61
30940909 2019
360
Ketamine‑induced bladder dysfunction is associated with extracellular matrix accumulation and impairment of calcium signaling in a mouse model. 61
30720140 2019
361
Retraction: An Overview of the Pathology and Emerging Treatment Approaches for Interstitial Cystitis/Bladder Pain Syndrome. 61
31032161 2019
362
Re: An Evaluation of the Pharmacotherapy for Interstitial Cystitis. 61
30664596 2019
363
Safety analysis of long-term phenazopyridine use for radiation cystitis. 61
31006341 2019
364
Vascular fibrinoid necrosis in the urinary bladder of ketamine abusers: A new finding that may provide a clue to the pathogenesis of ketamine-induced vesicopathy. 61
29527818 2019
365
Current management of radiation cystitis: a review and practical guide to clinical management. 61
30113758 2019
366
Transplant immunosuppressive drugs in urology. 61
31080770 2019
367
Critical Role of Mismatched HLA in Hemorrhagic Cystitis after Haploidentical Hematopoietic Stem Cell Transplantation. 61
30735721 2019
368
Higher Incidence of Hemorrhagic Cystitis Following Haploidentical Related Donor Transplantation Compared with Matched Related Donor Transplantation. 61
30579967 2019
369
[Comparison of effectiveness and complications between two different methods of augmentation cystoplasty]. 61
30996371 2019
370
Therapeutic potential of monoterpene α-thujone, the main compound of Thuja occidentalis L. essential oil, against malignant glioblastoma multiforme cells in vitro. 61
30825580 2019
371
[Clinical Efficacy of Modified BU/CY as Conditioning Regimen Combined with Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation in Young Acute Myeloid Leukemia Patients with Low or Intermediate Risk]. 61
30998138 2019
372
Hypoactivity of rat detrusor muscle in a model of cystitis: exacerbation by non-selective COX inhibitors and amelioration by a selective DP1 receptor antagonist. 61
30552456 2019
373
Early Tolerance Outcomes of Stereotactic Hypofractionated Accelerated Radiation Therapy Concomitant with Pelvic Node Irradiation in High-risk Prostate Cancer. 61
31011679 2019
374
Bladder necrosis and perforation in end-stage renal disease and recurrent urinary tract infection: A rare medical emergency. 61
31334054 2019
375
Clinical presentation, risk factors and pathogens involved in bacteriuria of pregnant women attending antenatal clinic of 3 hospitals in a developing country: a cross sectional analytic study. 61
31035943 2019
376
Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm. 61
30253040 2019
377
Management of Symptom Flares and Patient-reported Flare Triggers in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)-Findings From One Site of the MAPP Research Network. 61
30682464 2019
378
Comparison of Voiding Dysfunction Phenotypes in Women with Interstitial Cystitis/Bladder Pain and Myofascial Pelvic Pain: Results from the ICEPAC Trial. 61
30682465 2019
379
Clinical characteristics of self-reported nocturia in patients with interstitial cystitis, and effects of bladder hydrodistention (with fulguration of Hunner lesions) on nocturia. 61
30010251 2019
380
Comparison of outpatient reimbursement for interstitial cystitis/bladder pain syndrome and rheumatoid arthritis treatment in Taiwan: A nationwide population-based study. 61
30073771 2019
381
Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study. 61
29265766 2019
382
[A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis]. 61
31184015 2019
383
Efficacy and Safety of Noninvasive Intravesical Instillation of Onabotulinum Toxin-A for Overactive Bladder and Interstitial Cystitis/Bladder Pain Syndrome: Systematic Review and Meta-analysis. 61
30552935 2019
384
Sacral neuromodulation for female pelvic floor disorders. 61
31258941 2019
385
Bladder pain syndrome: Prevalence and routine clinical practice in women attending functional urology and urodynamics units in Spain. 61
30262204 2019
386
Risk factors for Candida urinary tract infections in dogs and cats. 61
30758081 2019
387
The potential role of folate metabolism in interstitial cystitis. 61
30293165 2019
388
Risk Factors for Interstitial Cystitis in the General Population and in Individuals With Depression. 61
30943693 2019
389
Re: Digital Quantitative Analysis of Mast Cell Infiltration in Interstitial Cystitis. 61
30759680 2019
390
Does repeated hydrodistension with transurethral fulguration for interstitial cystitis with Hunner's lesion cause bladder contraction? 61
31258947 2019
391
Emphysematous cystitis in an elderly Japanese patient with type 2 diabetes mellitus. 61
30899503 2019
392
The IOU Consensus Recommendations for Empirical Therapy of Cystitis in Nursing Home Residents. 61
30584657 2019
393
BK Virus Associated Haemorrhagic Cystitis. A systematic review of current prevention and treatment strategies. 61
30711618 2019
394
Urine Culture and Uncomplicated Cystitis: A Bigger Picture? 61
30797295 2019
395
Urine Culture and Uncomplicated Cystitis: The Minuses Outweigh the Pluses. 61
30797296 2019
396
Outpatient Robotic Unilateral Extravesical Ureteral Reimplantation in the Pediatric Population: Short-Term Assessment of Safety. 61
30218762 2019
397
Integrated Fourier Transform Infrared Imaging and Proteomics for Identification of a Candidate Histochemical Biomarker in Bladder Cancer. 61
30770125 2019
398
Radical radiotherapy in older patients with muscle invasive bladder cancer. 61
30630748 2019
399
Clinical significance of anti-dense fine speckled 70 antibody in patients with fibromyalgia. 61
29166758 2019
400
Small Fiber Polyneuropathy Is Prevalent in Patients Experiencing Complex Chronic Pelvic Pain. 61
29447372 2019
401
[Clinical features and risk factors of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation]. 61
30929383 2019
402
CUA Best-Practice Report: Pediatric hemorrhagic cystitis. 61
31059419 2019
403
Intravesical Administration of Xenogeneic Porcine Urothelial Cells Attenuates Cyclophosphamide-Induced Cystitis in Mice. 61
30675801 2019
404
Probable Donor-Derived Human Adenovirus Type 34 Infection in 2 Kidney Transplant Recipients From the Same Donor. 61
30882008 2019
405
MIF mediates bladder pain, not inflammation, in cyclophosphamide cystitis. 61
31289792 2019
406
Chronic Lower Urinary Tract Signs in Cats: Current Understanding of Pathophysiology and Management. 61
30736893 2019
407
Re: A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome. 61
30415770 2019
408
A Culture-Independent Analysis of the Microbiota of Female Interstitial Cystitis/Bladder Pain Syndrome Participants in the MAPP Research Network. 61
30917614 2019
409
Efficacy of pentosan polysulfate for the treatment of interstitial cystitis/bladder pain syndrome: results of a systematic review of randomized controlled trials. 61
30849922 2019
410
Urologic chronic pelvic pain syndrome: insights from the MAPP Research Network. 61
30560936 2019
411
Guidelines for patients with acute uncomplicated cystitis may not be a paper tiger: a call for its implementation in clinical routine. 61
30564871 2019
412
Editorial Comment on: Endoscopic Intravesical Fibrin Glue Application in the Treatment of Refractory Hemorrhagic Radiation Cystitis: A Single Cohort Pilot Study by Bove et al. (From: Bove P, Iacovelli V, Tirindelli MC, et al. J Endourol 2019;33:93-98; DOI: 10.1089/end.2018.0028). 61
30632409 2019
413
Green tea as an adjunctive therapy for treatment of acute uncomplicated cystitis in women: A randomized clinical trial. 61
30712716 2019
414
Endoscopic Intravesical Fibrin Glue Application in the Treatment of Refractory Hemorrhagic Radiation Cystitis: A Single Cohort Pilot Study. 61
30280911 2019
415
Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial. 61
30576011 2019
416
Mimickers of urothelial neoplasia. 61
30380401 2019
417
[Focused Abdominal Ultrasound in Emergency, Perioperative and Intensive Care Medicine]. 61
30769352 2019
418
The effect of herpes simplex virus vector-mediated gene therapy of protein phosphatase 1α on bladder overactivity and nociception. 61
30499116 2019
419
GAG replenishment therapy for bladder pain syndrome/interstitial cystitis. 61
30592544 2019
420
In premenopausal women with recurrent cystitis, increasing water intake for 12 months reduced recurrence. 61
30776805 2019
421
Single postoperative instillation for non-muscle invasive bladder cancer: are there still any indication? 61
30976571 2019
422
Duration of antibiotic treatment for common infections in English primary care: cross sectional analysis and comparison with guidelines. 61
30814052 2019
423
Association between child maltreatment and central sensitivity syndromes: a systematic review protocol. 61
30782933 2019
424
Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy. 61
30427093 2019
425
Canadian Urological Association Best Practice Report: Diagnosis and management of radiation-induced hemorrhagic cystitis. 61
30721124 2019
426
BK-virus and pathophysiology of associated diseases. 61
31131830 2019
427
IPSE, a urogenital parasite-derived immunomodulatory protein, ameliorates ifosfamide-induced hemorrhagic cystitis through downregulation of pro-inflammatory pathways. 61
30733505 2019
428
[Application of multiplex PCR assay to study early multiple herpesviruses infection during HSCT]. 61
30831627 2019
429
Absence of Global Stress Regulation in Escherichia coli Promotes Pathoadaptation and Novel c-di-GMP-dependent Metabolic Capability. 61
30796316 2019
430
Decreased antibiotic susceptibility of Enterobacteriaceae causing community-acquired urinary tract infections in French Amazonia. 61
30385068 2019
431
Virulence factors and antimicrobial resistance in uropathogenic Escherichiacoli strains isolated from cystitis and pyelonephritis 61
30761847 2019
432
The efficacy and safety of tazobactam/ceftolozane in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infection. 61
30420153 2019
433
Diagnosis in a Preclinical Model of Bladder Pain Syndrome Using a Au/ZnO Nanorod-based SERS Substrate. 61
30736472 2019
434
Symptom Duration in Patients With Urologic Chronic Pelvic Pain Syndrome is not Associated With Pain Severity, Nonurologic Syndromes and Mental Health Symptoms: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Network Study. 61
30452963 2019
435
Stress-induced autonomic dysregulation of mitochondrial function in the rat urothelium. 61
30575113 2019
436
The Effects of Neurokinin-1 Receptor Antagonist in an Experimental Autoimmune Cystitis Model Resembling Bladder Pain Syndrome/Interstitial Cystitis. 61
30196377 2019
437
Effects of intravesical administration of sensory neuron-specific receptor agonist on voiding function in rats with cyclophosphamide-induced cystitis. 61
31482020 2019
438
C-Phycocyanin Alleviates Bladder Inflammation and Dysfunction in Cyclophosphamide-Induced Cystitis in a Mouse Model by Inhibiting COX-2 and EP4. 61
31467580 2019
439
Hyperbaric oxygen significantly improves frequent urination, hyperalgesia, and tissue damage in a mouse long-lasting cystitis model induced by an intravesical instillation of hydrogen peroxide. 61
30411813 2019
440
Diagnostic Value of Glucose Transporter 1 (GLUT-1) Expression in Nested Variant of Urothelial Carcinoma. 61
30035295 2019
441
Comparative analysis of 13 HPV genotypes diagnosed in urine sediment cells vs. desquamated cervical epithelial cells 61
31134772 2019
442
Clinical, histopathologic, cystoscopic, and fluorescence in situ hybridization analysis of proliferative urethritis in 22 dogs. 61
30516855 2019
443
Treatment of Cystitis by Hungarian General Practitioners: A Prospective Observational Study. 61
31920676 2019
444
Use of a subcutaneous ureteral bypass device for treatment of bilateral proximal ureteral injury in a 9-month-old cat. 61
30886728 2019
445
Urinary infection or radiation cystitis? A prospective evaluation of urinary symptoms in patients submitted to pelvic radiotherapy. 61
31778433 2019
446
Emphysematous cystitis: review of current literature, diagnosis and management challenges. 61
31440461 2019
447
A wireless closed-loop system for optogenetic peripheral neuromodulation. 61
30602791 2019
448
The Current Evidence on the Association Between the Urinary Microbiome and Urinary Incontinence in Women. 61
31119104 2019
449
Overactive bladder and bladder pain syndrome/interstitial cystitis in primary Sjögren's syndrome patients: A nationwide population-based study. 61
31747429 2019
450
IgA nephropathy: Missed diagnosis and renal transplant. 61
30804285 2019
451
Reliability of Symptom-Based Diagnosis of Uncomplicated Cystitis. 61
30419565 2019
452
A Multicenter, Randomized, Placebo-Controlled Study Evaluating the Efficacy of a Combination of Propolis and Cranberry (Vaccinium macrocarpon) (DUAB®) in Preventing Low Urinary Tract Infection Recurrence in Women Complaining of Recurrent Cystitis. 61
31117097 2019
453
[Regulation of Cav3.2-mediated pain signals by hydrogen sulfide]. 61
31527362 2019
454
Primary Vesical Amyloidosis Masquerading as Vesical Calculus in a Retroviral Positive Patient. 61
30868041 2019
455
Osteopontin and Fatty Acid Binding Protein in Ifosfamide-treated Rats. 61
31410367 2019
456
Stereotactic Re-irradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: Preliminary Results. 61
30828565 2019
457
[Macrohaematuria in Anticoagulated Patients]. 61
30890085 2019
458
[2018 scientific breakthroughs in ambulatory general internal medicine]. 61
30657262 2019
459
Effect of Short-Course Oral Ciprofloxacin on Isoflavone Pharmacokinetics following Soy Milk Ingestion in Healthy Postmenopausal Women. 61
31097972 2019
460
[Tobacco Use and Utilization of Medical Services in Adolescence: An Analysis of the KiGGS Data]. 61
27855473 2019
461
A correlation study of BK Polyoma Virus infection and prostate Cancer among Sudanese patients - immunofluorescence and molecular based case-control study. 61
31548852 2019
462
Iron Chelation as Novel Treatment for Interstitial Cystitis. 61
30695781 2019
463
Single nucleotide polymorphism analysis in interstitial cystitis/painful bladder syndrome. 61
30973927 2019
464
Personal cell therapy for interstitial cystitis with autologous stromal vascular fraction stem cells. 61
31452686 2019
465
Verification of mesenchymal stem cell injection therapy for interstitial cystitis in a rat model. 61
31830131 2019
466
Role of NLRP3 inflammasome in the development of bladder pain syndrome interstitial cystitis. 61
30671141 2019
467
Stratification of Patients With Interstitial Cystitis/Bladder Pain Syndrome According to the Anatomical Bladder Capacity. 61
30170094 2019
468
Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome. 61
31828153 2019
469
Pathology and terminology of interstitial cystitis/bladder pain syndrome: A review. 61
30015351 2019
470
Nursing Management of Haemorrhagic Cystitis in Patients Undergoing Haematopoietic Stem Cell Transplantation: a Multicentre Italian Survey. 61
31528317 2019
471
Surgical Treatment of Eosinophilic Cystitis in Adults: A Report of Two Cases and a Literature Review. 61
29554647 2019
472
A rare x-ray image of emphysematous cystitis. 61
30406017 2019
473
Emphysematous cystitis. 61
30624190 2019
474
Prevention of recurrent urinary tract infections: bridging the gap between clinical practice and guidelines in Latin America. 61
31105773 2019
475
HBO2 for radiation cystitis 61
31689017 2019
476
Oxygen Venous Embolism After Hydrogen Peroxide Use During Percutaneous Nephrolithotomy. 61
30989125 2019
477
[Richter syndrome successfully treated with ibrutinib monotherapy: two case reports]. 61
31695008 2019
478
Urological Surveillance and Medical Complications in the United States Adult Spina Bifida Population. 61
28935364 2019
479
Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome. 61
30636972 2019
480
Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis. 61
30881921 2019
481
Concomitant primary ovarian paraganglioma neuroendocrinal differentiated urothelial tumor in a BOTOX-injected bladder: A case report. 61
30952024 2019
482
Increased risk of 100-day and 1-year infection-related mortality and complications in haploidentical stem cell transplantation. 61
31191064 2019
483
Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population. 61
31371924 2019
484
[Afferent nerve activity in relation to bladder sensation]. 61
31735754 2019
485
Clinical Outcomes of Volumetric Modulated Arc Therapy Following Intracavitary/Interstitial Brachytherapy in Cervical Cancer: A Single Institution Retrospective Experience. 61
31475110 2019
486
Impact of bladder volume on treatment planning and clinical outcomes of radiotherapy for patients with cervical cancer. 61
31440099 2019
487
A Novel Camptothecin Derivative 3j Inhibits Nsclc Proliferation Via Induction of Cell Cycle Arrest By Topo I-Mediated DNA Damage. 61
30523769 2019
488
[One year of infectious diseases in review]. 61
30629372 2019
489
Myxoma virus derived immune modulating proteins, M-T7 and Serp-1, reduce early inflammation after spinal cord injury in the rat model. 61
31038187 2019
490
Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection. 61
30643171 2019
491
Intra-Vesical Colistin for Pseudomonas aeruginosa Urinary Tract Infections. 61
30756071 2019
492
Is BK Virus-Associated Cystitis a Generalized Epithelial Disease? 61
30605908 2019
493
A Porcine Model for Urinary Tract Infection. 61
31824442 2019
494
A large bladder hematoma resulting from infectious hemorrhagic cystitis after pelvic reconstruction with transvaginal mesh: An unusual complication. 61
31105946 2019
495
Severe Hemorrhagic Cystitis Caused by Cyclophosphamide and Capecitabine Therapy in Breast Cancer Patients: Two Case Reports and Literature Review. 61
31043944 2019
496
Monotypic IgG1-kappa Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Report. 61
31019927 2019
497
Photoselective Vaporization of the Bladder for the Management of Radiation Cystitis-Technique and Initial Outcomes. 61
29777786 2019
498
Antibiotic treatment of Chlamydia-induced cystitis in the koala is linked to expression of key inflammatory genes in reactive oxygen pathways. 61
31415633 2019
499
What can we learn by examining variations in the use of urine culture in the management of acute cystitis? A retrospective cohort study with linked administrative data in British Columbia, Canada, 2005-2011. 61
30849104 2019
500
Polypoid Cystitis and Bilateral Hydronephrosis Mimicking Urothelial Carcinoma. 61
31179381 2019
501
Urinary Tract Infection in Children. 61
30592257 2019
502
Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin. 61
28868940 2019
503
A Systematic Review of Single-Dose Aminoglycoside Therapy for Urinary Tract Infection: Is It Time To Resurrect an Old Strategy? 61
30397061 2019
504
Accessory Traits and Phylogenetic Background Predict Escherichia coli Extraintestinal Virulence Better Than Does Ecological Source. 61
30085181 2019
505
Whole-genome sequence analysis of multidrug-resistant uropathogenic strains of Escherichia coli from Mexico. 61
31447566 2019
506
The Remarkable Biomechanical Properties of the Type 1 Chaperone-Usher Pilus: A Structural and Molecular Perspective. 61
30681068 2019
507
Blocking α2δ-1 Subunit Reduces Bladder Hypersensitivity and Inflammation in a Cystitis Mouse Model by Decreasing NF-kB Pathway Activation. 61
30863309 2019
508
Diverse Expression of Antimicrobial Activities Against Bacterial Vaginosis and Urinary Tract Infection Pathogens by Cervicovaginal Microbiota Strains of Lactobacillus gasseri and Lactobacillus crispatus. 61
31921075 2019
509
Diffusion-Weighted Magnetic Resonance Imaging: A New Tool for the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis. 61
30428470 2019
510
Posttraumatic stress disorder in interstitial cystitis/bladder pain syndrome: Relationship to patient phenotype and clinical practice implications. 61
30350890 2019
511
Evaluation of several botulinum toxins-A delivering systems into the bladder in interstitial cystitis/painful bladder syndrome (IC/PBS). 61
31763366 2019
512
The Vaginal and Urinary Microbiomes in Premenopausal Women With Interstitial Cystitis/Bladder Pain Syndrome as Compared to Unaffected Controls: A Pilot Cross-Sectional Study. 61
31024861 2019
513
Pulsed Electromagnetic Field Therapy as a Complementary Alternative for Chronic Pelvic Pain Management in an Interstitial Cystitis/Bladder Pain Syndrome Patient. 61
31949970 2019
514